データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Why Is Small Cap Amylyx Pharmaceuticals Stock Trading Higher On Wednesday?
Amylyx Jumps on Acquisition of Eiger's GLP-1 Drug
Amylyx Pharmaceuticals Shares Are Trading Higher After the Company Announced That It Acquired Avexitide From Eiger BioPharmaceuticals.
Amylyx Pharmaceuticals: FDA Has Agreed to the Primary Endpoint Expected to Be Utilized in Phase 3 >AMLX
Amylyx Pharmaceuticals: Data Readout Anticipated in 2026 >AMLX
Amylyx Pharmaceuticals: Expect to Begin the Phase 3 Program for Avexitide in PBH in 1Q 2025 >AMLX
データなし